Cargando…
Every 36-hour Gentamicin Dosing in Neonates with Hypoxic Ischemic Encephalopathy Receiving Hypothermia
OBJECTIVE: To examine the impact of a change in the empiric gentamicin dose from 5 mg/kg every 24h to 5 mg/kg every 36h on target drug concentration achievement in neonates with hypoxic ischemic encephalopathy (HIE) receiving therapeutic hypothermia. STUDY DESIGN: Gentamicin drug concentrations in n...
Autores principales: | Frymoyer, Adam, Lee, Shirley, Bonifacio, Sonia L., Meng, Lina, Lucas, Sarah S., Guglielmo, B. Joseph, Sun, Yao, Verotta, Davide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762884/ https://www.ncbi.nlm.nih.gov/pubmed/23702622 http://dx.doi.org/10.1038/jp.2013.59 |
Ejemplares similares
-
High-Dose Erythropoietin Population Pharmacokinetics in Neonates with Hypoxic-Ischemic Encephalopathy Receiving Hypothermia
por: Frymoyer, Adam, et al.
Publicado: (2017) -
Aminophylline for Renal Protection in Neonatal Hypoxic Ischemic Encephalopathy in the Era of Therapeutic Hypothermia
por: Chock, Valerie Y., et al.
Publicado: (2020) -
Dexmedetomidine Pharmacokinetics in Neonates with Hypoxic-Ischemic Encephalopathy Receiving Hypothermia
por: McAdams, Ryan M., et al.
Publicado: (2020) -
Theophylline Dosing and Pharmacokinetics for Renal Protection in Neonates with Hypoxic Ischemic Encephalopathy Undergoing Therapeutic Hypothermia
por: Frymoyer, Adam, et al.
Publicado: (2020) -
Risk of seizures in neonates with hypoxic-ischemic encephalopathy receiving hypothermia plus erythropoietin or placebo
por: Glass, Hannah C., et al.
Publicado: (2023)